Daratumumab-SC for Highly Sensitized Patients Awaiting Heart Transplantation

Clinical trial NCT04610320 · COMPLETED

Trial details

NCT number: NCT04610320
Sponsor: Ronald Witteles
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Allosensitization Heart Transplant Failure and Rejection

Start date: 2021-07-01
Primary completion: 2024-01-26
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.